The Evolving World of Knee Osteoarthritis Therapies: What You Need to Know
Knee osteoarthritis is a common and debilitating condition that affects millions of people worldwide. In this blog, we explore the evolving landscape of knee osteoarthritis therapies, from single intra-articular hyaluronic acid (IA-HA) injections to emerging breakthroughs like Zilosul and stem cell therapies. Is the Market Shifting Toward Single IA-HA Injections? Knee osteoarthritis therapies have seen a notable shift towards single IA-HA injections. These injections offer a minimally invasive approach to manage pain and inflammation associated with the condition, providing patients with a convenient and effective treatment option. Joyclu's Approval in Japan Joyclu , a single IA-HA injection therapy, recently received approval in Japan. This milestone reflects the growing global recognition of the efficacy and safety of IA-HA injections as a treatment for knee osteoarthritis. The Scenario of Emerging Therapies The knee osteoarthritis market is witnessing a surge in emerging thera